Abstract:Key PointsNeuroimaging studies have revealed an emerging pattern of generalized prefrontal cortex (PFC) dysfunction in drug-addicted individuals that is associated with worse outcome — more drug use, worse PFC-related task performance and greater likelihood of relapse.Widespread PFC activation in drug-addicted individuals upon taking cocaine or other drugs and upon presentation of drug-related cues is replaced by widespread PFC hypoactivity during exposure to higher-order emotional and cognitive challenges and/or during protracted withdrawal when not stimulated.The nature of the findings in PFC is different when abusers are studied during intoxication or craving and when they are studied during acute or protracted withdrawal, and this is to be expected considering the distinct role of the PFC in these processes.PFC regions may be implicated in what seem to be opposite processes. This may reflect the limited temporal resolution of imaging technologies or methodological variability. Processes also reflect the function of networks rather than isolated regions, so that the output of a region will differ as it connects with different networks.Although activity among PFC regions is highly integrated and flexible, such that any one region is involved in multiple functions, the dorsal PFC (including the dorsal anterior cingulate cortex, dorsolateral PFC and inferior frontal gyrus) has been predominantly implicated in top-down control and meta-cognitive functions (including awareness), the ventromedial PFC (including subgenual ACC and medial orbitofrontal cortex) in emotion regulation (including conditioning and assigning incentive salience to drugs and drug-related cues), and the ventrolateral PFC and lateral OFC in automatic response tendencies (for example, drug-related attention bias) and impulsivity.Dysfunction of these PFC regions may contribute to impaired response inhibition and salience attribution (iRISA) in addiction, neuropsychological mechanisms that underlie the development of craving, compulsive use and impaired self-awareness (previously labelled 'denial' of illness and/or need for treatment), which are characteristic symptoms of drug addiction.PFC dysfunction may in some instances precede drug use and confer vulnerability for (or protection against) developing substance use disorders.Specific biomarkers could be targeted for intervention purposes. For example, PFC abnormalities could be used to identify the children and adolescents who would benefit most from intensive drug abuse prevention efforts.The combination of targeted pharmacological interventions (for example, to enhance dopaminergic neurotransmission) with cognitive–behavioural exercises (for example, to enhance inhibitory control and non drug-related motivation, and reduce drug-related attention bias) could normalize select PFC functions. Ameliorating these deficits could help addicted subjects to engage in rehabilitation treatment.

Tackling addictive behaviors through memory suppression: A scoping review and perspective

Trying to forget alcohol: Brain mechanisms underlying memory suppression in young binge drinkers

Memory Reconsolidation Updating in Substance Addiction: Applications, Mechanisms, and Future Prospects for Clinical Therapeutics

Pharmacological Interventions on the Dopamine Motivation System Effectively Disturbed Cue-Induced Memory Reconsolidation Cocaine-Seeking Behavior for Rats

Twisted memories: Addiction-related engrams are strengthened by desire thinking

Cognitive enhancement as a treatment for drug addictions

A Memory Retrieval-Extinction Procedure to Prevent Drug Craving and Relapse

Advancements in addressing drug dependence: A review of promising therapeutic strategies and interventions

Involvement of Learning and Memory in the Development of Addictive Be-Havior and the Related Brain Mechanism

Neuroimaging and Intervening in Memory Reconsolidation of Human Drug Addiction

Distinct roles of excitatory and inhibitory neurons in the medial prefrontal cortex in the expression and reconsolidation of methamphetamine-associated memory in male mice

Targeting Neuroplasticity in Substance Use Disorders: Implications for Therapeutics

Neurobiology, psychotherapeutic interventions, and emerging therapies in addiction: a systematic review

Identifying the role of (dis)inhibition in the vicious cycle of substance use through ecological momentary assessment and resting-state fMRI

Neurobiological mechanisms and related clinical treatment of addiction: a review

The Neuropsychological Basis of Addictive Behaviour

Retrieval-extinction of Drug Memory Requires AMPA Receptor Trafficking

Mechanistic insights into the efficacy of memantine in treating certain drug addictions

Intentional forgetting in excessive behavior: direct suppression and thought substitution

Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications

Role of Amygdala in Drug Memory